Analysts: Cornerstone Therapeutics Inc (CRTX.OQ)

CRTX.OQ on NASDAQ Stock Exchange Capital Market

8.51USD
1:06pm EDT
Price Change (% chg)

$0.11 (+1.31%)
Prev Close
$8.40
Open
$8.33
Day's High
$8.52
Day's Low
$8.30
Volume
5,148
Avg. Vol
19,648
52-wk High
$10.34
52-wk Low
$3.10

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy 0.18 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.00 1.00 1.00 1.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 1 39.06 39.06 39.06 --
Quarter Ending Dec-13 1 38.67 38.67 38.67 --
Year Ending Dec-13 1 151.50 151.50 151.50 --
Year Ending Dec-14 1 163.16 163.16 163.16 --
Earnings (per share)
Quarter Ending Sep-13 1 0.18 0.18 0.18 --
Quarter Ending Dec-13 1 0.20 0.20 0.20 --
Year Ending Dec-13 1 0.58 0.58 0.58 --
Year Ending Dec-14 1 0.46 0.46 0.46 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 35.43 37.98 2.55 7.19
Quarter Ending Dec-12 36.04 34.93 1.11 3.09
Quarter Ending Sep-12 32.00 37.53 5.53 17.27
Quarter Ending Jun-12 18.84 21.47 2.63 13.98
Quarter Ending Mar-12 20.00 22.16 2.16 10.79
Earnings (per share)
Quarter Ending Mar-13 0.13 0.09 0.04 30.77
Quarter Ending Dec-12 0.10 -0.26 0.36 360.00
Quarter Ending Sep-12 0.32 0.19 0.13 40.62
Quarter Ending Jun-12 -0.02 0.11 0.13 -650.00
Quarter Ending Mar-12 0.10 0.12 0.02 20.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 39.06 39.06 39.06 39.06 --
Quarter Ending Dec-13 38.67 38.67 38.67 38.67 --
Year Ending Dec-13 151.50 151.50 151.50 151.50 --
Year Ending Dec-14 163.16 163.16 163.16 163.16 --
Earnings (per share)
Quarter Ending Sep-13 0.18 0.18 0.18 0.21 --
Quarter Ending Dec-13 0.20 0.20 0.20 0.23 --
Quarter Ending Dec-13 0.58 0.58 0.58 0.68 --
Quarter Ending Dec-14 0.46 0.46 0.46 0.46 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks